Clinical trials
Glaucoma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 8 |
| Unknown status | 6 |
| Terminated | 4 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondation Hôpital Saint-Joseph | 7 |
| Hôpital Privé de la Baie | 4 |
| University Hospital, Bordeaux | 4 |
| Allergan | 3 |
| Centre Hospitalier Universitaire Dijon | 3 |
| Fondation Ophtalmologique Adolphe de Rothschild | 3 |
| Laboratoires Thea | 3 |
| Sensimed AG | 3 |
| University Hospital, Grenoble | 3 |
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 50 |
| Glaucoma, Open-Angle | 8 |
| Ocular Hypertension | 5 |
| Macular Degeneration | 4 |
| Eye Diseases | 3 |
| Hypertension | 3 |
| Retinitis Pigmentosa | 3 |
| Cataract | 2 |
| Diabetes Mellitus | 2 |
| Macular Edema | 2 |
Trials
Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.